Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial
- 1 July 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9121), 17-20
- https://doi.org/10.1016/s0140-6736(98)01259-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?European Journal Of Cancer, 1998
- Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trialsAnnals of Oncology, 1997
- Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patientsGastroenterology, 1995
- Controlled trial of tamoxifen in patients with advanced hepatocellular carcinomaJournal of Hepatology, 1994
- Pathogenic Factors in Cirrhosis With and Without Hepatocellular Carcinoma: A Multicenter Italian StudyHepatology, 1994
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- 32P‐Postlabeling Analysis of DNA Adducts in Rats during Estrogen‐induced Hepatocarcinogenesis and Effect of Tamoxifen on DNA Adduct LevelJapanese Journal of Cancer Research, 1992
- Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifenJournal of Hepatology, 1990
- A phase II trial of tamoxifen in hepatocellular carcinomaCancer, 1990
- The effect of estrogen and tamoxifen on hepatocyte proliferation in Vivo and in VitroHepatology, 1989